For Families
Substance Use Treatment During Pregnancy in New Jersey
Pregnancy changes what a safe approach to substance use treatment looks like. This page covers why that is, and what to ask a provider — it is not medical advice.
Published: · Last updated: · 9 min read · By Christopher Veto, NCACIP

What this page can realistically offer, and where it stops
A pregnancy on top of substance use treatment brings in medical complexity that a quick search online tends to oversimplify or exaggerate. We're not in a position to tell any specific reader what treatment fits her pregnancy, how much of a medication is appropriate, or when switching course is wise \u2014 those calls belong to a clinician who actually knows the patient's history. What we can do here, for a Hudson County reader or anyone else, is lay out why pregnancy shifts the conversation, link to guidance from recognized medical bodies, and clear up confidentiality rules people often get wrong.
If you're pregnant and currently using any substance \u2014 alcohol, opioids, or even a prescribed medication you're thinking about stopping \u2014 the most useful move is contacting an OB provider or a substance use treatment provider right away, rather than looking for a general answer online or trying to handle it solo.
Why quitting suddenly during pregnancy isn't risk-free
With some substances, opioids especially, medical guidance actively discourages a sudden, unmonitored stop during pregnancy. ACOG has noted that medically supervised treatment with an opioid agonist medication tends to be preferred over unsupervised withdrawal for pregnant women with opioid use disorder, since withdrawal without medical backing correlates with higher relapse rates and can harm outcomes for both mother and pregnancy (ACOG Committee Opinion on Opioid Use and Opioid Use Disorder in Pregnancy).
This is precisely the kind of call that needs a clinician who sees the whole picture \u2014 we're not instructing anyone here, just flagging that "stop immediately" isn't automatically the safest route for every substance in every pregnancy, and that expert input matters more in this area than in most others we cover.
Why routine screening is designed not to single anyone out
ACOG's position is that substance use screening should happen for every prenatal patient at the first visit, not just ones a clinician suspects might have an issue. The reasoning given is that risk-based screening alone can miss genuine cases and can stigmatize patients who get flagged based on assumptions rather than a universal standard (ACOG Committee Opinion on Opioid Use and Opioid Use Disorder in Pregnancy).
So if an OB brings up substance use during a prenatal appointment, that's simply standard protocol under this framework \u2014 it isn't a signal that anything in particular is being assumed about that patient.
What the 42 CFR Part 2 confidentiality rule actually covers
Substance use treatment records get an extra layer of federal confidentiality beyond typical medical privacy law. Under 42 CFR Part 2, programs that receive federal assistance and provide substance use diagnosis, treatment, or referral generally can't disclose information identifying someone with a substance use disorder without written consent, apart from narrow exceptions such as a medical emergency or court order (U.S. Department of Health and Human Services, Understanding Confidentiality of Substance Use Disorder Patient Records).
These rules are legitimately complicated, and how they intersect with prenatal records, hospital charting, or child welfare reporting can shift by state and by situation. Nothing here substitutes for legal advice \u2014 if confidentiality worries you specifically, ask a treatment program directly how it applies Part 2, and think about consulting an attorney if the stakes feel significant.
Why disclosing a pregnancy early on matters, practically
Whether treatment is already underway or still being considered, letting any provider \u2014 OB, prescriber, or program \u2014 know about a pregnancy as soon as possible lets them tailor care to the situation. That might mean different screening tools, closer monitoring, or more coordination between clinicians once pregnancy enters the picture.
This isn't a box to check for its own sake; it's simply practical. A provider who doesn't know about a pregnancy can't factor it into whatever care is already happening.
Questions worth asking a program or provider
If you're pregnant and evaluating a treatment option, these are fair, direct questions to raise rather than presuming a program already has experience with pregnancy.
- Is there staff, or a coordinating OB provider, with actual experience treating pregnant patients?
- How does the program sync substance use treatment with prenatal care appointments?
- What's the program's practical approach to confidentiality under 42 CFR Part 2?
- How would the program communicate with a hospital or delivery team if needed?
- What does follow-up care look like once the baby is born, not just during the pregnancy itself?
Where to look for further guidance
Both SAMHSA and ACOG publish public-facing guidance aimed at clinicians treating pregnant and parenting people with substance use disorders, but it's readable enough to be useful background for patients and families too. SAMHSA's national helpline (1-800-662-4357) can help connect callers with treatment referral options. Our own line can help a Jersey City or Hudson County caller think through questions worth asking and resources worth exploring \u2014 we don't provide treatment or make clinical calls ourselves.
Frequently Asked Questions
If I'm pregnant, should I just stop using a substance right now?
We can't give an individual answer to that — it hinges on the specific substance and a person's full medical picture. For some substances, clinicians specifically warn against quitting suddenly and without supervision during pregnancy. Reach out to an OB provider or prescriber promptly instead of deciding alone.
Could telling my doctor about substance use while pregnant get me in legal trouble?
That depends on jurisdiction and circumstances, and a federal law (42 CFR Part 2) shapes a lot of how this information can be disclosed. We're not positioned to offer legal advice — ask your provider how they handle it, and talk to a lawyer if you're worried.
Why would my OB ask about substance use when I don't think it applies to me?
ACOG calls for asking every prenatal patient the same screening questions, regardless of perceived risk, specifically so cases aren't missed and patients aren't singled out. It's routine protocol, not a judgment about you.
Can your team tell me which medication or treatment path fits my pregnancy?
No. Jersey City Detox Support Services connects people to information and referrals — we don't treat patients or give clinical guidance. That call belongs to a qualified prescriber working directly with you.
What does 42 CFR Part 2 actually do?
It's a federal rule adding extra confidentiality around substance use treatment records, usually requiring written consent before that information moves between providers. It gets technical fast — ask a provider or lawyer about your specific situation.
Does nursing change the substance use treatment picture?
It might, depending on what's involved. That's a conversation for a treating clinician or pediatrician, not something we can weigh in on here.
Sources
Last reviewed: August 29, 2026
- ACOG — Opioid Use and Opioid Use Disorder in Pregnancy (Committee Opinion)
- ACOG — Opioid Use Disorder and Pregnancy (patient FAQ)
- SAMHSA — Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder
- U.S. Department of Health and Human Services — Understanding Confidentiality of SUD Patient Records (42 CFR Part 2)
- SAMHSA National Helpline
Related Resources
- Women's Addiction Treatment Programs in New Jersey
Gender-specific programming, childcare logistics, and safety resources.
- Medication-Assisted Treatment (MAT) in New Jersey
What MAT means in plain terms, described neutrally without dosing advice.
- Paying for Detox in New Jersey
How insurance and coverage questions typically work for detox and treatment.
- Crisis and Emergency Resources
What to do in an emergency, including 911 and 988.
Questions About Next Steps?
Call for general treatment information and referral support. We can help you prepare questions to ask independently operated providers.